Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma

Background: Programmed death ligand-1 (PD-L1) is a biomarker for assessing the immune microenvironment, prognosis, and response to immune checkpoint inhibitors in the clinical treatment of lung adenocarcinoma (LUAD), but it does not work for all patients. This study aims to discover alternative biom...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in genetics Vol. 13; p. 863796
Main Authors Xia, Zhi, Rong, Xueyao, Dai, Ziyu, Zhou, Dongbo
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.04.2022
Subjects
Online AccessGet full text

Cover

Loading…